Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$20,982,560
+$4,406,128 QoQ
Shares Held
10,087,770
+48.5% QoQ
Ownership
2.92%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Derivatives in ALLO

reported options exposure · as of Jun 30, 2026
CallValue
$149,344
CallShares
71,800
PutValue
$132,704
PutShares
63,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. ALLO ranks #58 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in ALLO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $132,704 63,800
2026-06-30 $20,982,560 10,087,770
2026-06-30 $149,344 71,800
2026-03-31 $16,576,432 6,793,620
2026-03-31 $78,080 32,000
2026-03-31 $150,060 61,500
2025-12-31 $25,756 18,800
2025-12-31 $16,592,644 12,111,420
2025-12-31 $107,682 78,600
2025-09-30 $25,544 20,600
2025-09-30 $32,984 26,600
2025-09-30 $17,324,729 13,971,557
2025-06-30 $11,585,444 10,252,606
2025-06-30 $23,391 20,700
2025-06-30 $81,360 72,000
2025-03-31 $36,354 24,900
2025-03-31 $108,624 74,400
2025-03-31 $14,896,860 10,203,329
2024-12-31 $120,771 56,700
2024-12-31 $11,393,573 5,349,096
2024-12-31 $31,737 14,900
2024-09-30 $111,720 39,900
2024-09-30 $15,120 5,400
2024-09-30 $14,110,863 5,039,594
2024-06-30 $98,792 42,400
2024-06-30 $5,700,351 2,446,503
2024-06-30 $31,921 13,700
2024-03-31 $66,603 14,900
2024-03-31 $13,916,114 3,113,225
2024-03-31 $12,069 2,700
2023-12-31 $13,010,855 4,053,226
2023-12-31 $138,993 43,300
2023-12-31 $29,211 9,100
2023-09-30 $13,046,546 4,115,630
2023-09-30 $132,189 41,700
2023-09-30 $18,703 5,900
2023-06-30 $23,559,493 4,740,341
2023-06-30 $167,489 33,700
2023-06-30 $73,059 14,700
2023-03-31 $101,270 20,500
2023-03-31 $21,481,604 4,348,503
2023-03-31 $126,464 25,600
2022-12-31 $103,156 16,400
2022-12-31 $3,398,511 540,304
2022-12-31 $91,205 14,500
2022-09-30 $262,440 24,300
2022-09-30 $192,240 17,800
2022-09-30 $9,642,833 892,855
2022-06-30 $927,537 81,363
2022-06-30 $264,480 23,200